x

Search for a clinical trial

* (*) mandatory field

70 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

UNITED KINGDOM

South Glamorgan
CARDIFF

FRANCE

AUVERGNE-RHONE-ALPES
PIERRE-BENITE

GERMANY

Nordrhein-Westfalen
KÖLN

GERMANY

Nordrhein-Westfalen
MÜNSTER

Recruiting trial
Ongoing trial
A Phase I/II Safety, Dose Finding and Feasibility Trial of MB-CART19.1 in Patients With Relapsed or Refractory CD19 Positive B Cell Malignancies
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

SPAIN

Madrid
MADRID

Recruiting trial
Ongoing trial
A phase I/II, multicenter, open-label study of MAK683 in adult patients with advanced malignancies - ES
Hospital Universitario 12 de Octubre
Unidad de Ensayos Clínicos de Fase Temprana en Hematología

ITALY

EMILIA ROMAGNA
BOLOGNA

Recruiting trial
Ongoing trial
Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Policlinico S. Orsola-Malpighi - Area S. Orsola
Dipartimento di Ematologia e Scienze Oncologiche

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques Universitaires UCL Saint-Luc
Pneumologie_Oncologie thoracique

Multinational clinical trial(s)

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US